Andrew McKeown
Senior Vice President of Strategic Finance and Investor Relations
Replay available
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.

Senior Vice President of Strategic Finance and Investor Relations
Chief Executive Officer
President and Chief Operating Officer
Chief Financial Officer
Evercore Analyst
Learing Partners Analyst
City Representative
Raymond James Analyst
Watch the replay and follow the connected company analysis, news, and investor updates for Mirum Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.879 Hello and welcome to the MIRIN Pharmaceutics Report's first quarter 2025 financial 00:00:05.879 -- 00:00:09.604 results. My name is Carla and I will be coordinating your call today. 00:00:09.604 -- 00:00:13.669 During the presentation, you can register to ask questions by pressing star followed 00:00:13.669 -- 00:00:17.774 by one on your telephone keypad. If you change your mind, please press star followed 00:00:17.774 -- 00:00:22.881 by two. I would now like to hand you over to Andrew McKeown, Senior Vice President 00:00:22.881 -- 00:00:26.606 of Strategic Finance and Investor Relations to begin. 00:00:26.606 -- 00:00:29.928 Andrew, please go ahead when you're ready. 00:00:30.035 -- 00:00:32.478 Thanks, Carla, and good afternoon, everyone. 00:00:32.478 -- 00:00:37.023 I'd like to welcome you to Miriam Pharmaceuticals' first quarter 2025 conference call. 00:00:37.023 -- 00:00:41.127 I'm joined today by our CEO, Chris Peets, our President and Chief Operating Officer, 00:00:41.127 -- 00:00:44.831 Peter Radovich, and Eric Buerkle, our Chief Financial Officer. 00:00:44.831 -- 00:00:48.135 Joanne Kwan, our Chief Medical Officer, could not be with us today as she's at a medical 00:00:48.135 -- 00:00:52.380 conference in Europe. Earlier today, Miriam issued a news release announcing the company's 00:00:52.380 -- 00:00:54.902 results for the first quarter 2025. 00:00:54.902 -- 00:00:58.606 Copies of this news release and SEC filings can be found in the Investors section of 00:00:58.606 -- 00:01:02.590 our website. Before we start, I'd like to remind you that during the course of this conference 00:01:02.590 -- 00:01:06.473 call, we will be making certain forward-looking statements based on management's current 00:01:06.473 -- 00:01:10.397 ...